525 related articles for article (PubMed ID: 20131292)
1. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
[TBL] [Abstract][Full Text] [Related]
2. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations.
Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA
J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392
[TBL] [Abstract][Full Text] [Related]
3. Aicardi-Goutières syndrome (AGS).
Stephenson JB
Eur J Paediatr Neurol; 2008 Sep; 12(5):355-8. PubMed ID: 18343173
[TBL] [Abstract][Full Text] [Related]
4. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.
Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ
Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309
[TBL] [Abstract][Full Text] [Related]
5. Aicardi-Goutières syndrome.
Crow YJ
Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
[TBL] [Abstract][Full Text] [Related]
6. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
[TBL] [Abstract][Full Text] [Related]
8. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
Livingston JH; Crow YJ
Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
Crow YJ; Chase DS; Lowenstein Schmidt J; Szynkiewicz M; Forte GM; Gornall HL; Oojageer A; Anderson B; Pizzino A; Helman G; Abdel-Hamid MS; Abdel-Salam GM; Ackroyd S; Aeby A; Agosta G; Albin C; Allon-Shalev S; Arellano M; Ariaudo G; Aswani V; Babul-Hirji R; Baildam EM; Bahi-Buisson N; Bailey KM; Barnerias C; Barth M; Battini R; Beresford MW; Bernard G; Bianchi M; Billette de Villemeur T; Blair EM; Bloom M; Burlina AB; Carpanelli ML; Carvalho DR; Castro-Gago M; Cavallini A; Cereda C; Chandler KE; Chitayat DA; Collins AE; Sierra Corcoles C; Cordeiro NJ; Crichiutti G; Dabydeen L; Dale RC; D'Arrigo S; De Goede CG; De Laet C; De Waele LM; Denzler I; Desguerre I; Devriendt K; Di Rocco M; Fahey MC; Fazzi E; Ferrie CD; Figueiredo A; Gener B; Goizet C; Gowrinathan NR; Gowrishankar K; Hanrahan D; Isidor B; Kara B; Khan N; King MD; Kirk EP; Kumar R; Lagae L; Landrieu P; Lauffer H; Laugel V; La Piana R; Lim MJ; Lin JP; Linnankivi T; Mackay MT; Marom DR; Marques Lourenço C; McKee SA; Moroni I; Morton JE; Moutard ML; Murray K; Nabbout R; Nampoothiri S; Nunez-Enamorado N; Oades PJ; Olivieri I; Ostergaard JR; Pérez-Dueñas B; Prendiville JS; Ramesh V; Rasmussen M; Régal L; Ricci F; Rio M; Rodriguez D; Roubertie A; Salvatici E; Segers KA; Sinha GP; Soler D; Spiegel R; Stödberg TI; Straussberg R; Swoboda KJ; Suri M; Tacke U; Tan TY; te Water Naude J; Wee Teik K; Thomas MM; Till M; Tonduti D; Valente EM; Van Coster RN; van der Knaap MS; Vassallo G; Vijzelaar R; Vogt J; Wallace GB; Wassmer E; Webb HJ; Whitehouse WP; Whitney RN; Zaki MS; Zuberi SM; Livingston JH; Rozenberg F; Lebon P; Vanderver A; Orcesi S; Rice GI
Am J Med Genet A; 2015 Feb; 167A(2):296-312. PubMed ID: 25604658
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of genotype-phenotype variability in siblings with Aicardi Goutières Syndrome (AGS).
de Barcelos IP; Woidill S; Gavazzi F; Modesti NB; Sevagamoorthy A; Vanderver A; Adang L
Mol Genet Metab; 2024 May; 142(1):108346. PubMed ID: 38368708
[TBL] [Abstract][Full Text] [Related]
11. Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres syndrome.
Izzotti A; Longobardi M; Cartiglia C; Anzuini F; Arrigo P; Fazzi E; Orcesi S; Piana RL; Pulliero A
J Child Neurol; 2012 Jan; 27(1):51-60. PubMed ID: 21862834
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
Cuadrado E; Michailidou I; van Bodegraven EJ; Jansen MH; Sluijs JA; Geerts D; Couraud PO; De Filippis L; Vescovi AL; Kuijpers TW; Hol EM
J Immunol; 2015 Apr; 194(8):3623-33. PubMed ID: 25769924
[TBL] [Abstract][Full Text] [Related]
13. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.
Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T
Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular phenotype of Aicardi-Goutieres syndrome.
Rice G; Patrick T; Parmar R; Taylor CF; Aeby A; Aicardi J; Artuch R; Montalto SA; Bacino CA; Barroso B; Baxter P; Benko WS; Bergmann C; Bertini E; Biancheri R; Blair EM; Blau N; Bonthron DT; Briggs T; Brueton LA; Brunner HG; Burke CJ; Carr IM; Carvalho DR; Chandler KE; Christen HJ; Corry PC; Cowan FM; Cox H; D'Arrigo S; Dean J; De Laet C; De Praeter C; Dery C; Ferrie CD; Flintoff K; Frints SG; Garcia-Cazorla A; Gener B; Goizet C; Goutieres F; Green AJ; Guet A; Hamel BC; Hayward BE; Heiberg A; Hennekam RC; Husson M; Jackson AP; Jayatunga R; Jiang YH; Kant SG; Kao A; King MD; Kingston HM; Klepper J; van der Knaap MS; Kornberg AJ; Kotzot D; Kratzer W; Lacombe D; Lagae L; Landrieu PG; Lanzi G; Leitch A; Lim MJ; Livingston JH; Lourenco CM; Lyall EG; Lynch SA; Lyons MJ; Marom D; McClure JP; McWilliam R; Melancon SB; Mewasingh LD; Moutard ML; Nischal KK; Ostergaard JR; Prendiville J; Rasmussen M; Rogers RC; Roland D; Rosser EM; Rostasy K; Roubertie A; Sanchis A; Schiffmann R; Scholl-Burgi S; Seal S; Shalev SA; Corcoles CS; Sinha GP; Soler D; Spiegel R; Stephenson JB; Tacke U; Tan TY; Till M; Tolmie JL; Tomlin P; Vagnarelli F; Valente EM; Van Coster RN; Van der Aa N; Vanderver A; Vles JS; Voit T; Wassmer E; Weschke B; Whiteford ML; Willemsen MA; Zankl A; Zuberi SM; Orcesi S; Fazzi E; Lebon P; Crow YJ
Am J Hum Genet; 2007 Oct; 81(4):713-25. PubMed ID: 17846997
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.
Uyur Yalçın E; Maraş Genç H; Kara B
Turk J Pediatr; 2015; 57(5):504-8. PubMed ID: 27411419
[TBL] [Abstract][Full Text] [Related]
16. Aicardi-Goutières syndrome: description of a late onset case.
D'Arrigo S; Riva D; Bulgheroni S; Chiapparini L; Lebon P; Rice G; Crow YJ; Pantaleoni C
Dev Med Child Neurol; 2008 Aug; 50(8):631-4. PubMed ID: 18754903
[TBL] [Abstract][Full Text] [Related]
17. Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?
Fazzi E; Cattalini M; Orcesi S; Tincani A; Andreoli L; Balottin U; De Simone M; Fredi M; Facchetti F; Galli J; Giliani S; Izzotti A; Meini A; Olivieri I; Plebani A
Autoimmun Rev; 2013 Feb; 12(4):506-9. PubMed ID: 22940555
[TBL] [Abstract][Full Text] [Related]
18. Aicardi-Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies.
Cuadrado E; Vanderver A; Brown KJ; Sandza A; Takanohashi A; Jansen MH; Anink J; Herron B; Orcesi S; Olivieri I; Rice GI; Aronica E; Lebon P; Crow YJ; Hol EM; Kuijpers TW
Ann Rheum Dis; 2015 Oct; 74(10):1931-9. PubMed ID: 24906636
[TBL] [Abstract][Full Text] [Related]
19. Typing TREX1 gene in patients with systemic lupus erythematosus.
Fredi M; Bianchi M; Andreoli L; Greco G; Olivieri I; Orcesi S; Fazzi E; Cereda C; Tincani A
Reumatismo; 2015 Jun; 67(1):1-7. PubMed ID: 26150267
[TBL] [Abstract][Full Text] [Related]
20. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.
Orebaugh CD; Fye JM; Harvey S; Hollis T; Perrino FW
J Biol Chem; 2011 Nov; 286(46):40246-54. PubMed ID: 21937424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
